MedDataX Logo

Time Effect on the Predictability of Different Grafting for Gingival Recession RT 1

NCT ID: NCT05976451

Last Updated: 2023-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-01

Study Completion Date

2023-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study was to evaluate time effect on the clinical predictability of collagen matrix Xenograft (CMX) with melatonin gel versus connective tissue graft (CTG) and determine whether it is proposed to be an alternative in multiple adjacent gingival recession (MAGR) in recession type one (RT1)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

this study was conducted to evaluate time effect on the clinical predictability of collagen matrix Xenograft (CMX) with melatonin gel versus connective tissue graft (CTG) and determine whether it is proposed to be an alternative in multiple adjacent gingival recession

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingival Recession Types One(RT1)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

collagen matrix

melatonin in collagen matrix with Modified Coronally Advanced Tunneling Technique (MCAT)

Group Type EXPERIMENTAL

melatonin with collagen matrix

Intervention Type COMBINATION_PRODUCT

(CMX) with melatonin in the esthetic zone using Modified Coronally Advanced Tunneling Technique (MCAT)

connective tissue graft (CTG)

connective tissue graft with Modified Coronally Advanced Tunneling Technique (MCAT)

Group Type ACTIVE_COMPARATOR

connective tissue graft (CTG)

Intervention Type COMBINATION_PRODUCT

control group connective tissue graft using Modified Coronally Advanced Tunneling Technique (MCAT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

melatonin with collagen matrix

(CMX) with melatonin in the esthetic zone using Modified Coronally Advanced Tunneling Technique (MCAT)

Intervention Type COMBINATION_PRODUCT

connective tissue graft (CTG)

control group connective tissue graft using Modified Coronally Advanced Tunneling Technique (MCAT)

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of RT1 GRs of the maxillary or mandibular arch in the esthetic zone with a GR depth ≥2 mm,
* patients \>18 years old,
* Full mouth plaque index score \<20%
* Systemically and periodontally healthy patients.

Exclusion Criteria

* Smokers
* Patients with periodontitis stage III and IV were previous surgical treatment of GR,
* Pregnant or breastfeeding women; P
* Patients with para-functional habits or any source of occlusal trauma.
Minimum Eligible Age

19 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

mahetab mohamed abdel el wahab

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, Cairo Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1011

Identifier Type: -

Identifier Source: org_study_id